Omalizumab, an Anti-IgE mAb, Receives Approval for the...

Omalizumab, an Anti-IgE mAb, Receives Approval for the Treatment of Chronic Idiopathic/Spontaneous Urticaria

Wu, Keith C P, Jabbar-Lopez, Zarif K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
135
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1038/jid.2014.362
Date:
January, 2015
File:
PDF, 111 KB
english, 2015
Conversion to is in progress
Conversion to is failed